• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Gender Disparity in Head and Neck Cancer Treatment and Outcomes

  • in AJO · Audio · Oncology
  • — 9 Jun, 2018
Gender Disparity in Head and Neck Cancer Treatment and Outcomes
Jed Katzel
Gender Disparity in Head and Neck Cancer Treatment and Outcomes
AudioMedica News
Gender Disparity in Head and Neck Cancer Treatment and Outcomes
Gender Disparity in Head and Neck Cancer Treatment and Outcomes
00:00 / 7 mins
Apple Podcasts Spotify Stitcher
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-3623"/>

Subscribe: Apple Podcasts | Spotify | Stitcher

CHICAGO—Women and men were treated differently for the same tumor stages of head and neck cancer (HNC) and had different outcomes in a study with patients surveyed over a fifteen-year period in Santa Clara, California. The findings—using the generalized competing event (GCE) assessment model that balanced the risk of cancer death against non-cancer death—has prompted a call to reassess the influence of gender on treatment decision-making.

Study author Jed A. Katzel MD, a medical oncologist with Kaiser Permanente in Santa Clara, talks with the Audio Journal of Onclogy about his new data from GCE modeling he reported at the 2018 annual meeting of the American Society of Clinical Oncology (ASCO).

(Abstract LBA6002: Are women with head and neck cancer undertreated?)

https://meetinglibrary.asco.org/record/161984/abstract

Commenting on the findings ASCO Expert Joshua A Jones, MD MA, a radiation oncologist at the Perelman School of Medicine at University of Pennsylvania in Philadelphia said: “We don’t know why women are getting less treatment and having worse outcomes and we need to find out. Though these findings are specific to California the disparities we see are startling and worth considering in treatment discussions in everyday practice.”

 

You may also like...

  • Audio Journal of Oncology 13.8, December 2005 Audio Journal of Oncology 13.8, December 2005 7 Dec, 2005
  • Active Surveillance Better for Which Renal Cell Cancers? Active Surveillance Better for Which Renal Cell Cancers? 17 Apr, 2017
  • Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos 5 Aug, 2009
  • Oncology Times Broadcast News with the Audio Journal of Oncology – Insulin-Like Growth Factor Inhibition In Lung Cancer Oncology Times Broadcast News with the Audio Journal of Oncology – Insulin-Like Growth Factor Inhibition In Lung Cancer 6 Apr, 2009

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Pembrolizuab Monotherapy Extended Survival in Advanced Lung Cancer
  • Next story Geriatric Assessment Improved Outcomes for Older Patients with Cancer
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Childhood Obesity—Whose Business Is It?
    • New Front Line Standard for Older Patients with…
  • Home
  • Oncology
  • AJO
  • Gender Disparity in Head and Neck Cancer Treatment and Outcomes

© COPYRIGHT 2020 AUDIOMEDICA.COM.